The 3D printing market has witnessed tremendous growth in M&A activities in terms of the number of deals announced between 2010 and 2016. The large tech companies have shown interest in the 3D printing technology through various acquisitions. The driving factors behind the increase in M&A activities include the need to increase scale, substantial growth of startup companies, intense competition, and the need for companies to improve their technology, product, and services portfolio. Significant opportunities exist for the 3D printing market in the Asia-Pacific region. The market has been experiencing advancements in printers and printing technologies, improvements in materials used, and developments in skilled workforce.
3D PRINTING MARKET TO GROW AT A HIGH CAGR BETWEEN 2016 AND 2022
The 3D printing market is expected to reach USD 30.19 billion by 2022, at a CAGR of 28.5% between 2016 and 2022. 3D printing is used to develop prototypes and end products in industries such as automotive, medical, aerospace, defense, dental, biomedical, jewelry, art, architecture, fashion designing, and interior designing among others. Along with these, electronics, robotics, spacecraft, construction, organ transplantations, food, and other industries have also started adopting the 3D printing technology. The market is growing rapidly, and it is now focusing on the production of end parts with the development of technologies and metal powdered materials.
The break-up of profile of primary participants is given below:
- By Company Type: Tier 1 – 25%, Tier 2 – 45% and Tier 3 –30%
- By Designation: C-Level – 35%, Director Level – 40%, Others – 25%
- By Region: North America – 45%, Europe – 35%, APAC – 15%, RoW – 5%
The major players in the 3D printing market include 3D Systems Corporation (U.S.), Stratasys Ltd. (U.S. & Israel), the ExOne Company(U.S.), Voxeljet AG (Germany), Arcam Group (Sweden), SLM Solutions Group AG (Germany), EOS GmbH (Germany), EnvisionTEC GmbH (Germany), Materialise NV (Belgium), Sciaky Inc. (U.S.), Concept Laser GmbH (Germany), Autodesk, Inc. (U.S.), Hoganas AB (Sweden), Renishaw PLC (U.K.).
The report will help leaders/new entrants in this market in the following ways:
1. This report categorizes M&A during 2010–2016 by deal volume, segment, cross-border and domestic, and geography with a review of the big deals giving buyers an insight into the latest M&A trends in the 3D printing market.
2. The report provides an overview of the 3D printing market, analyzing key component segments and end-user segments. Furthermore, stakeholders can get an understanding of the pulse of M&A, patents, and investments.
3. The report reviews key M&A strategies, private equity investors, and patents adopted by top 3D printing companies and analyzes the top five assignees of the published patents.
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.6 Market Stakeholders
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Key Data From Secondary Sources
2.4 Key Data From Primary Sources
2.5 Assumptions for the Study
3 Executive Summary
4 Premium Insights
4.1 Bioabsorbable Stents Market, By Material
4.2 Bioabsorbable Stents Market, By Absorption Rate
4.3 Bioabsorbable Stents Market, By End User
4.4 Bioabsorbable Stents Market, By Region
5 Market Overview
5.2 Market Dynamics
188.8.131.52 Rapidly Growing Aging Population and Increased Risk of Coronary Artery Disease and Peripheral Artery Disease in the Elderly
184.108.40.206 Strong Product Pipeline
220.127.116.11 High Device Costs
18.104.22.168 Emerging Markets to Offer High-Growth Opportunities for Market Players
22.214.171.124 Presence of Substitutes
126.96.36.199 High Risk of Complications
6 Regulatory Scenario
6.2 FDA and CE Approvals
6.3 PMA Approvals and Government Certificates
7 Bioabsorbable Stents Market, Pipeline Products
8 Bioabsorbable Stents Market, By Material
8.2 Polymeric Stents
8.3 Metallic Stents
9 Bioabsorbable Stents Market, By Absorption Rate
9.2 Slow-Absorption Stents
9.3 Fast-Absorption Stents
10 Bioabsorbable Stents Market, By Drug
10.3 Limus-Based Drugs
11 Bioabsorbable Stents Market, By Application
11.2 Coronary Artery Disease
11.3 Peripheral Artery Disease
12 Bioabsorbable Stents Market, By End User
12.3 Cardiac Centers
13 Bioabsorbable Stents Market, By Region
13.2 North America
13.3.4 Rest of Europe (RoE)
13.4.4 Rest of Asia
13.5 Rest of the World
14 Competitive Landscape
14.2 Market Share Analysis
14.3 Competitive Situations & Trends
14.3.1 New Product Launches & Product Approvals
15 Company Profiles
(Company at A Glance, Business Overview, Products Offered, Key Strategy, Recent Developments, SWOT Analysis & MnM View)*
15.2 Abbott Laboratories
15.3 Reva Medical, Inc.
15.4 Elixir Medical Corporation
15.5 Kyoto Medical Planning Co., Ltd.
15.6 Amaranth Medical, Inc.
15.7 Arterial Remodeling Technologies
15.9 Xenogenics Corporation (A Subsidiary of Multicell Technologies, Inc.)
15.10 Meril Life Sciences
15.11 SMT (Part of Sahajanand Group of Companies)
15.12 Tepha, Inc.
15.13 Arterius Limited
*Details on Company at A Glance, Recent Financials, Products Offered, Strategies & Insights, & Recent Developments Might Not Be Captured in Case of Unlisted Companies.
16.1 Insights From Industry Experts
16.2 Discussion Guide
Europe commanded the largest share of the global bioabsorbable stents market in 2016, followed by North America. Europe commanded the largest share of the global market in 2016 and is expected to grow at the highest CAGR of 42.5% during the forecast period.
The major driving factors are the increasing focus of the companies on clinical trials of bioabsorbable stents, increasing aging population, technological advancements, and patients’ preference for minimally invasive therapies. However, factors such as the high prices of these stents may hamper the growth of the market.
The bioabsorbable stents market is dominated by few players. Prominent players in the market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Reva Medical, Inc. (U.S.), Arterial Remodeling Technologies (France), Kyoto Medical Planning. Co. Ltd. (Japan).
This report covers the global bioabsorbable stents market by material, absorption rate, drugs application, end user, and region.
Bioabsorbable Stents Market, by Material
- Polymeric Stents
- Metallic Stents
Bioabsorbable Stents Market, by Absorption Rate
- Fast Absorption
- Slow Absorption
Bioabsorbable Stents Market, by Drug
- Limus-based Drugs
- Paclitaxel Drugs
Bioabsorbable Stents Market, by Application
- Coronary Artery Disease
- Peripheral Artery Disease
Bioabsorbable Stents Market, by End User
- Cardiac Centers
Bioabsorbable Stents Market, by Region
- North America
-- Rest of Europe (RoE)
-- Rest of Asia (RoA)
- Rest of the World (RoW)
Based on material, the market is segmented into polymer stents, and metallic stents. The polymeric stents segment is expected to grow at the highest CAGR. This is attributed to the various facts such as polymer-based bioabsorbable stents comprise PLLA polymers that are naturally biodegradable. These stents have a polymer coating of poly-D,L-lactide, which enables the controlled release of various drugs.
By absorption rate, the market is sub-segmented into slow absorbable stents and fast absorbable stents. In 2016, slow absorbable stents is expected to account for the largest share of the absorption rate. The slow rate of absorption enables the longer duration of drug release within the arteries. This ensures efficient healing. These factors may enable the market to witness significant growth in the future.
Based on application, the market is segmented into coronary artery disease and peripheral artery disease. In 2016, the coronary artery disease segment is expected to grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the factors such as increasing focus of companies towards developing bioabsorbable stents that can be used in coronary procedures and growing patient preference for minimally invasive surgical procedures.
Based on end user, the market is segmented into hospitals and cardiac centers. The hospital segment is expected to dominate the market and grow at the highest CAGR during the forecast period. The high growth of this segment is attributed to the increasing patient pool and the rise in CAD and PAD prevalence, and initiatives and support programs to provide cost-effective and quality treatments to patients will enhance the affordability of a number of medical devices, including bioabsorbable stents.
The global bioabsorbable stents market is dominated by Europe, followed by North America. North American market is expected to grow at the highest CAGR of 46.1% during the forecast period. This growth can be attributed due to the increase in aging population, unhealthy lifestyle habits, and the strong healthcare infrastructure in this market.
The bioabsorbable stents market has fewer numbers of players. Prominent players in the market include Abbott (U.S.), Elixir Medical Corporation (U.S.), Kyoto Medical Co. LTD. (Japan), Reva Medical Inc. (U.S.), Arterial Remodeling Technologies (France), Tepha Inc. (U.S.), Meril Life Sciences Pvt. Ltd. (India) among others.
The global bioabsorbable stents market is expected to reach USD 2.4 billion by 2021 from USD 0.4 billion by 2016, at a CAGR of 42.5% during the forecast period. The major driving factors are the increasing focus of the companies on clinical trials of bioabsorbable stents, increasing aging population, technological advancements, and patients’ preference for minimally invasive therapies. However, factors such as the high prices of these stents may hamper the growth of the market.
Europe is the largest regional market for bioabsorbable stents, accounting for 60% of the total market in 2016. The North American market is expected to grow at the highest CAGR of 46.1% during the forecast period, due to the increase in aging population, unhealthy lifestyle habits, and the strong healthcare infrastructure in this market.
Traditionally, bare metal stents were used for the treatment of coronary and peripheral artery diseases. Due to various complications, such as stent thrombosis and the increased risk of restenosis, these stents were replaced by drug-eluting stents, which in turn were succeeded by bioabsorbable stents. Bioabsorbable stents have overcome the complexities and disadvantages of drug-eluting stents. They restore the normal ability of the artery to contract & relax, improve abnormal endothelial function, and permit remodeling of the vessel.
Apart from the comprehensive regional analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. The company profiles comprise basic views on key players and their product portfolios, developments, and strategies adopted. The above-mentioned market research data, current market sizes, and forecast of future trends will help key players and new entrants make informed decisions regarding product offerings, geographical focus, change in strategic approach, R&D investments, and levels of output in order to remain successful.
Reasons to Buy the Report:
The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help firms, garner a greater market share. Firms purchasing the report can use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.
The report provides insights on the following pointers:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the bioabsorbable stents market. The report analyzes the bioabsorbable stent market by material, absorption rate, application, end user, and region
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and new product launches in the bioabsorbable stent market
- Competitive Assessment: In-depth assessment of market strategies, geographical and business segments, and product portfolios of the leading players in the bioabsorbable stent market
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for bioabsorbable stent market across geographies
- Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the bioabsorbable stent market
- Amaranth Medical, Inc.
- Arterial Remodeling Technologies
- Arterius Limited
- Elixir Medical Corporation
- Kyoto Medical Planning Co., Ltd.
- Meril Life Sciences
- Reva Medical, Inc.
- SMT (Part of Sahajanand Group of Companies)
- Tepha, Inc.
- Xenogenics Corporation (A Subsidiary of Multicell Technologies, Inc.)